Long-acting somatostatin analogues decrease blood transfusion requirements in patients with refractory gastrointestinal bleeding associated with angiodysplasia

Alimentary Pharmacology and Therapeutics

Volumn 36, Issue 6, 2012, Pages 587-593

  Bon, C ^a   Aparicio, T ^a   Vincent, M ^b   Mavros, M ^c   Bejou, B ^a   Raynaud, J J ^a   Zampeli, E ^c   Airinei, G ^a   Sautereau, D ^b   Benamouzig, R ^a   Michopoulos, S ^c  

^a AVICENNE HOSPITAL   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

^c ALEXANDRA HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; IRON; LAR SANDOSTATIN; OCTREOTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIODYSPLASIA; ARTICLE; BLOOD TRANSFUSION; CAPSULE ENDOSCOPY; CLINICAL ARTICLE; COLONOSCOPY; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENDOSCOPIC THERAPY; FEMALE; GASTROINTESTINAL ANGIODYSPLASIA; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; HUMAN; MALE; PRIORITY JOURNAL; SUPPLEMENTATION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANGIODYSPLASIA; BLOOD TRANSFUSION; COLONOSCOPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; HORMONES; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOMATOSTATIN; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84865524015     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12000     Document Type: Article

References (38)

1. Boley SJ, Sammartano R, Adams A, DiBiase A, Kleinhaus S, Sprayregen S,. On the nature and etiology of vascular ectasias of the colon. Degenerative lesions of aging. Gastroenterology 1977; 72: 650-60. (Pubitemid 8097606)
2. Boley SJ, Brandt LJ,. Vascular ectasias of the colon-1986. Dig Dis Sci 1986; 31: 26S-42S.
3. Foutch PG, Rex DK, Lieberman DA,. Prevalence and natural history of colonic angiodysplasia among healthy asymptomatic people. Am J Gastroenterol 1995; 90: 564-7.
4. Vreeburg EM, Snel P, de Bruijne JW, Bartelsman JF, Rauws EA, Tytgat GN,. Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol 1997; 92: 236-43. (Pubitemid 27076468)
5. Ohmiya N, Yano T, Yamamoto H, et al,. Diagnosis and treatment of obscure GI bleeding at double balloon endoscopy. Gastrointest Endosc 2007; 66: S72-7. (Pubitemid 47263464)
6. Chalasani N, Cotsonis G, Wilcox CM,. Upper gastrointestinal bleeding in patients with chronic renal failure: role of vascular ectasia. Am J Gastroenterol 1996; 91: 2329-32. (Pubitemid 26383195)
7. Bhutani MS, Gupta SC, Markert RJ, Barde CJ, Donese R, Gopalswamy N,. A prospective controlled evaluation of endoscopic detection of angiodysplasia and its association with aortic valve disease. Gastrointest Endosc 1995; 42: 398-402.
8. Veyradier A, Balian A, Wolf M, et al,. Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract. Gastroenterology 2001; 120: 346-53. (Pubitemid 32147631)
9. Lanas A, Garcia-Rodriguez LA, Polo-Tomas M, et al,. The changing face of hospitalisation due to gastrointestinal bleeding and perforation. Aliment Pharmacol Ther 2011; 33: 585-91.
10. Pavey DA, Craig PI,. Endoscopic therapy for upper-GI vascular ectasias. Gastrointest Endosc 2004; 59: 233-8. (Pubitemid 38199217)
11. Sebastian S, O'Morain CA, Buckley MJ,. Review article: current therapeutic options for gastric antral vascular ectasia. Aliment Pharmacol Ther 2003; 18: 157-65. (Pubitemid 36951651)
12. Junquera F, Feu F, Papo M, et al,. A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. Gastroenterology 2001; 121: 1073-9. (Pubitemid 33022086)
13. Bauditz J, Lochs H, Voderholzer W,. Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide. Endoscopy 2006; 38: 1036-9. (Pubitemid 44615243)
14. Dabak V, Kuriakose P, Kamboj G, Shurafa M,. A pilot study of thalidomide in recurrent GI bleeding due to angiodysplasias. Dig Dis Sci 2008; 53: 1632-5.
15. Ge ZZ, Chen HM, Gao YJ, et al,. Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation. Gastroenterology 2011; 141: 1629-37.
16. Kurosaki M, Saegert W, Abe T, Ludecke DK,. Expression of vascular endothelial growth factor in growth hormone-secreting pituitary adenomas: special reference to the octreotide treatment. Neurol Res 2008; 30: 518-22. (Pubitemid 352008712)
17. Ludwig D, Terai S, Bruning A, Stange EF,. Long-term haemodynamic effects of octreotide on postprandial splanchnic hyperemia in humans: a placebo-controlled echo-doppler study. Aliment Pharmacol Ther 1999; 13: 1119-29. (Pubitemid 29374116)
18. Szilagyi A, Ghali MP,. Pharmacological therapy of vascular malformations of the gastrointestinal tract. Can J Gastroenterol 2006; 20: 171-8.
19. Nardone G, Rocco A, Balzano T, Budillon G,. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 1999; 13: 1429-36. (Pubitemid 29516254)
20. Scaglione G, Pietrini L, Russo F, Franco MR, Sorrentini I,. Long-acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angiodysplasia. Aliment Pharmacol Ther 2007; 26: 935-42. (Pubitemid 47346712)
21. Brown C, Subramanian V, Wilcox CM, Peter S,. Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: an overview and systematic review of prospective observational studies. Dig Dis Sci 2010; 55: 2129-34.
22. Almadi M, Ghali PM, Constantin A, Galipeau J, Szilagyi A,. Recurrent obscure gastrointestinal bleeding: dilemmas and success with pharmacological therapies. Case series and review. Can J Gastroenterol 2009; 23: 625-31.
23. Blich M, Fruchter O, Edelstein S, Edoute Y,. Somatostatin therapy ameliorates chronic and refractory gastrointestinal bleeding caused by diffuse angiodysplasia in a patient on anticoagulation therapy. Scand J Gastroenterol 2003; 38: 801-3. (Pubitemid 36920506)
24. Bowers M, McNulty O, Mayne E,. Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease. Br J Haematol 2000; 108: 524-7. (Pubitemid 30196248)
25. De Palma GD, Salvatori F, Masone S, et al,. Acute gastrointestinal bleeding following aortic valve replacement in a patient with Heyde's sindrome. Case report. Minerva Gastroenterol Dietol 2007; 53: 291-3.
26. Munítiz Ruiz V, García Pérez B, Serrano Jiménez A, et al,. Multiple angiodysplasia of the small intestine. A diagnostic and therapeutic challenge. Gastroenterol Hepatol 2004; 27: 311-3. (Pubitemid 38679834)
27. Rivera M, Lucero J, Guerrero A, et al,. Octreotide in the treatment of angiodysplasia in patients with advanced chronic renal failure. Nefrologia 2005; 25: 332-5.
28. Rossini FP, Arrigoni A, Pennazio M,. Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine. Am J Gastroenterol 1993; 88: 1424-7. (Pubitemid 23259519)
29. Junquera F, Saperas E, Videla S, et al,. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia. Am J Gastroenterol 2007; 102: 254-60. (Pubitemid 46160536)
30. Orsi P, Guatti-Zuliani C, Okolicsanyi L,. Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract. Dig Liver Dis 2001; 33: 330-4. (Pubitemid 32537019)
31. Molina IJ, Perez GB, Hernandez AM, Mateos Rodriguez JM, Duenas SC, Fernandez BM,. Octreotide long acting release for severe obscure gastrointestinal haemorrhage in elderly patients with serious comorbidities. Med Clin (Barc) 2009; 133: 667-70.
32. Garrido A, Sayago M, Lopez J, Leon R, Bellido F, Marquez JL,. Thalidomide in refractory bleeding due to gastrointestinal angiodysplasias. Rev Esp Enferm Dig 2012; 104: 69-71.
33. Junquera F, Saperas E, de Torres I, Vidal MT, Malagelada JR,. Increased expression of angiogenic factors in human colonic angiodysplasia. Am J Gastroenterol 1999; 94: 1070-6. (Pubitemid 29173630)
34. D'Amato RJ, Loughnan MS, Flynn E, Folkman J,. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994; 91: 4082-5. (Pubitemid 24139577)
35. Danesi R, Agen C, Benelli U, et al,. Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995). Clin Cancer Res 1997; 3: 265-72. (Pubitemid 27107304)
36. Dasgupta P,. Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis. Pharmacol Ther 2004; 102: 61-85. (Pubitemid 38429986)
37. Lawnicka H, Stepien H, Wyczolkowska J, Kolago B, Kunert-Radek J, Komorowski J,. Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture. Biochem Biophys Res Commun 2000; 268: 567-71. (Pubitemid 30119662)
38. Dray X, Camus M, Coelho J, Ozenne V, Pocard M, Marteau P,. Treatment of gastrointestinal angiodysplasia and unmet needs. Dig Liver Dis 2011; 43: 515-22.